Labiana Health, S.A. (BME:LAB)

Spain flag Spain · Delayed Price · Currency is EUR
4.780
0.00 (0.00%)
Last updated: Dec 4, 2025, 12:07 PM CET
139.00%
Market Cap 33.44M
Revenue (ttm) 71.67M
Net Income (ttm) 904.36K
Shares Out 7.00M
EPS (ttm) 0.13
PE Ratio 36.97
Forward PE 13.26
Dividend n/a
Ex-Dividend Date n/a
Volume 150
Average Volume 1,813
Open 4.700
Previous Close 4.780
Day's Range 4.700 - 4.780
52-Week Range 1.940 - 4.900
Beta 0.22
RSI 73.45
Earnings Date Apr 22, 2026

About Labiana Health

Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, North America, rest of European Union, and internationally. The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products. It also provides sterile, lyophilized dosage forms, bacterial vaccines and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name. In addition, the company offers contrac... [Read more]

Sector Healthcare
Founded 1958
Employees 369
Stock Exchange Madrid Stock Exchange
Ticker Symbol LAB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.